Literature DB >> 26703938

Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis.

Marco Pagani1,2, Johanna Öberg3, Fabrizio De Carli4, Andrea Calvo5, Cristina Moglia5, Antonio Canosa5, Flavio Nobili6, Silvia Morbelli7,8, Piercarlo Fania9, Angelina Cistaro9, Adriano Chiò5,10,11.   

Abstract

OBJECTIVES: Positron emission tomography (PET) and volume of interest (VOI) analysis have recently shown in amyotrophic lateral sclerosis (ALS) an accuracy of 93% in differentiating patients from controls. The aim of this study was to disclose by spatial independent component analysis (ICA) the brain networks involved in ALS pathological processes and evaluate their discriminative value in separating patients from controls. EXPERIMENTAL
DESIGN: Two hundred fifty-nine ALS patients and 40 age- and sex-matched control subjects underwent brain 18F-2-fluoro-2-deoxy-D-glucose PET (FDG-PET). Spatial ICA of the preprocessed FDG-PET images was performed. Intensity values were converted to z-scores and binary masks were used as data-driven VOIs. The accuracy of this classifier was tested versus a validated system processing intensity signals in 27 brain meta-VOIs. A support vector machine was independently applied to both datasets and the 'leave-one-out' technique verified the general validity of results. PRINCIPAL OBSERVATIONS: The 8 components selected as pathophysiologically meaningful discriminated patients from controls with 99.0% accuracy, the discriminating value of bilateral cerebellum/midbrain alone representing 96.3%. Among the meta-VOIs, right temporal lobe alone reached an accuracy of 93.7%.
CONCLUSIONS: Spatial ICA identified in a very large cohort of ALS patients distinct spatial networks showing a high discriminatory value, improving substantially on the previously obtained accuracy. The cerebellar/midbrain component accounted for the highest accuracy in separating ALS patients from controls. Spatial ICA and multivariate analysis perform better than univariate semi-quantification methods in identifying the neurodegenerative features of ALS and pave the way for inclusion of PET in clinical trials and early diagnosis.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  amyotrophic lateral sclerosis; discriminant analysis; independent component analysis; meta-volumes of interest; positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 26703938      PMCID: PMC6867238          DOI: 10.1002/hbm.23078

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  68 in total

Review 1.  Independent component analysis at the neural cocktail party.

Authors:  G D Brown; S Yamada; T J Sejnowski
Journal:  Trends Neurosci       Date:  2001-01       Impact factor: 13.837

2.  Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.

Authors:  Jennifer L Shaffer; Jeffrey R Petrella; Forrest C Sheldon; Kingshuk Roy Choudhury; Vince D Calhoun; R Edward Coleman; P Murali Doraiswamy
Journal:  Radiology       Date:  2012-12-11       Impact factor: 11.105

3.  An information-maximization approach to blind separation and blind deconvolution.

Authors:  A J Bell; T J Sejnowski
Journal:  Neural Comput       Date:  1995-11       Impact factor: 2.026

4.  Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI.

Authors:  Jan Kassubek; Alexander Unrath; Hans-Jürgen Huppertz; Dorothée Lulé; Thomas Ethofer; Anne-Dorte Sperfeld; Albert C Ludolph
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2005-12

5.  Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study.

Authors:  Esther Verstraete; Martijn P van den Heuvel; Jan H Veldink; Niels Blanken; René C Mandl; Hilleke E Hulshoff Pol; Leonard H van den Berg
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Principal component analysis of FDG PET in amnestic MCI.

Authors:  Flavio Nobili; Dario Salmaso; Silvia Morbelli; Nicola Girtler; Arnoldo Piccardo; Andrea Brugnolo; Barbara Dessi; Stig A Larsson; Guido Rodriguez; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-22       Impact factor: 9.236

7.  Cortical hypermetabolism in MCI subjects: a compensatory mechanism?

Authors:  A Ashraf; Z Fan; D J Brooks; P Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-30       Impact factor: 9.236

8.  The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain.

Authors:  Robert C Welsh; Laura M Jelsone-Swain; Bradley R Foerster
Journal:  Front Hum Neurosci       Date:  2013-06-10       Impact factor: 3.169

9.  Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis.

Authors:  Carsten Keil; Tino Prell; Thomas Peschel; Viktor Hartung; Reinhard Dengler; Julian Grosskreutz
Journal:  BMC Neurosci       Date:  2012-11-08       Impact factor: 3.288

10.  Automatic selection of resting-state networks with functional magnetic resonance imaging.

Authors:  Silvia Francesca Storti; Emanuela Formaggio; Roberta Nordio; Paolo Manganotti; Antonio Fiaschi; Alessandra Bertoldo; Gianna Maria Toffolo
Journal:  Front Neurosci       Date:  2013-05-20       Impact factor: 4.677

View more
  20 in total

1.  Dynamic brain glucose metabolism identifies anti-correlated cortical-cerebellar networks at rest.

Authors:  Dardo G Tomasi; Ehsan Shokri-Kojori; Corinde E Wiers; Sunny W Kim; Şukru B Demiral; Elizabeth A Cabrera; Elsa Lindgren; Gregg Miller; Gene-Jack Wang; Nora D Volkow
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-23       Impact factor: 6.200

Review 2.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

3.  Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics.

Authors:  Donatienne Van Weehaeghe; Martijn Devrome; Michel Koole; Koen Van Laere; Georg Schramm; Joke De Vocht; Wies Deckers; Kristof Baete; Philip Van Damme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-20       Impact factor: 9.236

4.  Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.

Authors:  Arianna Sala; Leonardo Iaccarino; Piercarlo Fania; Emilia G Vanoli; Federico Fallanca; Caterina Pagnini; Chiara Cerami; Andrea Calvo; Antonio Canosa; Marco Pagani; Adriano Chiò; Angelina Cistaro; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-07       Impact factor: 9.236

5.  The Detection of Invisible Abnormal Metabolism in the FDG-PET Images of Patients With Anti-LGI1 Encephalitis by Machine Learning.

Authors:  Jian Pan; Ruijuan Lv; Guifei Zhou; Run Si; Qun Wang; Xiaobin Zhao; Jiangang Liu; Lin Ai
Journal:  Front Neurol       Date:  2022-05-30       Impact factor: 4.086

Review 6.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

7.  Separating dopamine D2 and D3 receptor sources of [11C]-(+)-PHNO binding potential: Independent component analysis of competitive binding.

Authors:  Kelly Smart; Jean-Dominique Gallezot; Nabeel Nabulsi; David Labaree; Ming-Qiang Zheng; Yiyun Huang; Richard E Carson; Ansel T Hillmer; Patrick D Worhunsky
Journal:  Neuroimage       Date:  2020-03-19       Impact factor: 6.556

Review 8.  Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.

Authors:  Federica Agosta; Daniele Altomare; Cristina Festari; Stefania Orini; Federica Gandolfo; Marina Boccardi; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Flavio Nobili; Zuzana Walker; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-01       Impact factor: 9.236

9.  Resting-State Networks as Simultaneously Measured with Functional MRI and PET.

Authors:  Alexandre Savio; Sarah Fünger; Masoud Tahmasian; Srinivas Rachakonda; Andrei Manoliu; Christian Sorg; Timo Grimmer; Vince Calhoun; Alexander Drzezga; Valentin Riedl; Igor Yakushev
Journal:  J Nucl Med       Date:  2017-03-02       Impact factor: 10.057

Review 10.  Hybrid PET/MR Imaging and Brain Connectivity.

Authors:  Marco Aiello; Carlo Cavaliere; Marco Salvatore
Journal:  Front Neurosci       Date:  2016-03-01       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.